|
Group Post |
Omicron now dominant strain of coronavirus in the U.S, 73% of new cases |
mike kraft |
|
Group Post |
The likely omicron variant symptoms based on your COVID vaccine status |
mike kraft |
|
Group Post |
Bivalent updated COVID-19 boosters struggle to prevent subvariant transmission – reseqarcher says new approaches are necessary |
mike kraft |
|
Group Post |
Europe Overview: facing new round of shutdowns amid virus surge |
mike kraft |
|
Group Post |
A guide to whether Johnson & Johnson vaccine recipients should get a booster shot — and how they might do so. --NY Times |
mike kraft |
|
Group Post |
New Banana-Derived Therapy Is Effective Against All Known Coronaviruses and Flu Strains |
mike kraft |
|
Group Post |
What do coronavirus variants mean for your masks? |
mike kraft |
|
Group Post |
Analysis: The pace of global warming may be accelerating. But not everyone agrees. |
mike kraft |
|
Group Post |
Comparing the Pfizer and Moderna Covid vaccines for young children |
mike kraft |
|
Group Post |
Omicron relatives -- BA.4 and BA.5-- are behind a fresh wave of COVID-19 in South Africa, and could be signs of a more predictable future for SARS-CoV-2. |
mike kraft |
|
Group Post |
Biden top COVID coordinators leaving in April, Brown University Dean Dr. Jha to take over |
mike kraft |
|
Group Post |
WHO official opposes boosters before 1st vaccines reach poor countries |
mike kraft |
|
Group Post |
FDA approves Pfizer vaccines for younger teens, 12-15 |
mike kraft |
|
Group Post |
Severe allergic reactions reported in the US after getting COVID-19 vaccine, but CDC says cases are rare |
mike kraft |
|
Group Post |
New government report descibes how climate change is affecting all regions of the U.S. |
mike kraft |
|
Group Post |
Low-income communities benefit most from COVID vaccination--study |
mike kraft |
|
Group Post |
India: virus death toll passes 300,000, 3rd highest in world as virus hits rural areas |
mike kraft |
|
Group Post |
Do fully vaccinated persons who also had COVID need a booster? |
mike kraft |
|
Group Post |
Early US indicators show ongoing slight rise in COVID-19 |
mike kraft |
|
Group Post |
Research suggests why the ‘Alpha’ Coronavirus Variant Became So Powerful |
mike kraft |
|
Group Post |
U.S. sending sending 9 million Covid vaccine doses to Africa and 2 more million to countries elsewhere |
mike kraft |
|
Group Post |
Malaria: New lines of research to fight the disease |
mike kraft |
|
Group Post |
German company's CureVac's COVID-19 vaccine failed in preliminary trial results |
mike kraft |
|
Group Post |
Webinar: Climate resilience in the health care system" Wednesday, Dec. 15, 12:30-1 PM ET |
mike kraft |
|
Group Post |
Masks and the new COVID-19 variant: What some experts are saying |
mike kraft |
Recent Comments